» Articles » PMID: 32971532

Predictors at Admission of Mechanical Ventilation and Death in an Observational Cohort of Adults Hospitalized With Coronavirus Disease 2019

Abstract

Background: Coronavirus disease (COVID-19) can cause severe illness and death. Predictors of poor outcome collected on hospital admission may inform clinical and public health decisions.

Methods: We conducted a retrospective observational cohort investigation of 297 adults admitted to 8 academic and community hospitals in Georgia, United States, during March 2020. Using standardized medical record abstraction, we collected data on predictors including admission demographics, underlying medical conditions, outpatient antihypertensive medications, recorded symptoms, vital signs, radiographic findings, and laboratory values. We used random forest models to calculate adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for predictors of invasive mechanical ventilation (IMV) and death.

Results: Compared with age <45 years, ages 65-74 years and ≥75 years were predictors of IMV (aORs, 3.12 [95% CI, 1.47-6.60] and 2.79 [95% CI, 1.23-6.33], respectively) and the strongest predictors for death (aORs, 12.92 [95% CI, 3.26-51.25] and 18.06 [95% CI, 4.43-73.63], respectively). Comorbidities associated with death (aORs, 2.4-3.8; P < .05) included end-stage renal disease, coronary artery disease, and neurologic disorders, but not pulmonary disease, immunocompromise, or hypertension. Prehospital use vs nonuse of angiotensin receptor blockers (aOR, 2.02 [95% CI, 1.03-3.96]) and dihydropyridine calcium channel blockers (aOR, 1.91 [95% CI, 1.03-3.55]) were associated with death.

Conclusions: After adjustment for patient and clinical characteristics, older age was the strongest predictor of death, exceeding comorbidities, abnormal vital signs, and laboratory test abnormalities. That coronary artery disease, but not chronic lung disease, was associated with death among hospitalized patients warrants further investigation, as do associations between certain antihypertensive medications and death.

Citing Articles

Disparities in Salmonellosis Incidence for US Counties with Different Social Determinants of Health Profiles Are Also Mediated by Extreme Weather: A Counterfactual Analysis of Laboratory Enteric Disease Surveillance (LEDS) Data From 1997 through 2019.

Weller D, Tierney R, Verlander S, Bruce B, Rose E J Food Prot. 2024; 87(12):100379.

PMID: 39414235 PMC: 11620915. DOI: 10.1016/j.jfp.2024.100379.


Syndromic Gastrointestinal Panel Diagnostic Tests Have Changed our Understanding of the Epidemiology of -Foodborne Diseases Active Surveillance Network, 2010-2021.

Ray L, Payne D, Rounds J, Trevejo R, Wilson E, Burzlaff K Open Forum Infect Dis. 2024; 11(6):ofae199.

PMID: 38868306 PMC: 11167669. DOI: 10.1093/ofid/ofae199.


Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis.

Wang S, Zhu R, Zhang C, Guo Y, Lv M, Zhang C PLoS One. 2023; 18(10):e0292021.

PMID: 37815980 PMC: 10564240. DOI: 10.1371/journal.pone.0292021.


Development and validation of a prediction model for mechanical ventilation based on comorbidities in hospitalized patients with COVID-19.

Zhang Y, Zhu Y, Zhu D, Yu B, Liu T, Wang L Front Public Health. 2023; 11:1227935.

PMID: 37522004 PMC: 10375294. DOI: 10.3389/fpubh.2023.1227935.


Evaluating disparities by social determinants in hospital admission decisions for patients with COVID-19 quaternary hospital early in the pandemic.

Olds P, Musinguzi N, Geisler B, Haberer J Medicine (Baltimore). 2023; 102(10):e33178.

PMID: 36897732 PMC: 9997198. DOI: 10.1097/MD.0000000000033178.